Skip to content

A real world study of extramedullary multiple myeloma in Zhejiang Province

A real world study of extramedullary multiple myeloma in Zhejiang Province

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300070583
Enrollment
Unknown
Registered
2023-04-17
Start date
2023-05-01
Completion date
Unknown
Last updated
2023-06-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

multiple myeloma

Interventions

Patients with multiple myeloma:N/A

Sponsors

The First Affiliated Hospital of Medical College, Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) From July 2015 to 2022.6, the newly diagnosed multiple myeloma at the hematology treatment center participating in the project; (2) According to IMWG2014 diagnostic criteria, patients diagnosed as multiple myeloma need to start systemic treatment immediately; (3) At least one course of treatment and efficacy evaluation can obtain survival information of patients; (4) The results of physical examination and imaging (including B-ultrasound, CT, MR and/or PET-CT) of the patient at the initial visit or at the time of disease recurrence/progression suggest the presence or absence of extramedullary myeloma.

Exclusion criteria

Exclusion criteria: (1) Lost patients: unable to find patients through existing measures and obtain survival information of patients; (2) At the time of initial diagnosis or disease progression/recurrence, the patient did not undergo physical examination and imaging detection to indicate whether extramedullary lesions were involved; (3) The patient did not sign the medical notice (including that the hospital will use its medical data to publish relevant scientific research papers or conduct academic exchanges), or clearly refused to use its medical data for academic exchanges.

Design outcomes

Primary

MeasureTime frame
Incidence of extramedullary involvement in myeloma;

Secondary

MeasureTime frame
overall survival of EMM patients;

Countries

China

Contacts

Public ContactCai Zhen

The First Affiliated Hospital of Medical College, Zhejiang University

caiz@zju.edu.cn+86 13657190311

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026